Beximco Pharmaceuticals PLC began its journey in 1976 and initially imported medicines from Bayer, Germany, and Upjohn, USA, for the local market. In 1980, the company started manufacturing medicines under licensing agreements, followed by the launch of its own brands in 1983. Over the decades, Beximco Pharma has grown into a leading pharmaceutical manufacturer in Bangladesh, focusing on quality, innovation, and affordable healthcare. Its modern manufacturing facilities meet international regulatory standards, supporting its growing reputation in global markets. Today, Beximco Pharma produces more than 500 products across various therapeutic categories, including antibiotics, cardiovascular medicines, diabetes treatments, and respiratory drugs. It exports medicines to over 50 countries worldwide. In 2016, it became the first Bangladeshi pharmaceutical company to export prescription medicines to the United States. With more than 4,700 employees, the company continues to expand its global presence through research, advanced manufacturing, and a commitment to improving patient health.